Clinical Trial Update: Autologous Transplantation for Chronic Myelogenous Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating autologous stem cell transplantation for chronic myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Myelogenous Leukemia | Phase 2 | Status: COMPLETED